<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Kragelund Blum | Activity</title>
	<link>https://recash.wpsoul.net/members/sandraheron1/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/sandraheron1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Kragelund Blum.</description>
	<lastBuildDate>Wed, 29 Jul 2026 16:07:14 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">6341dbbf2d687f0af67be0df42a5f31c</guid>
				<title>Kragelund Blum posted an update: Opioid abuse is a major health problem. The objective of the [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/142671/</link>
				<pubDate>Sat, 04 Jan 2025 10:32:29 +0000</pubDate>

									<content:encoded><![CDATA[<p>Opioid abuse is a major health problem. The objective of the present study was to evaluate the potentially disruptive side effects and therapeutic potential of a novel antagonist (D24M) of the mu-/delta-opioid receptor (MOR/DOR) heterodimer in male rats. Administration of high doses of D24M (1 &amp; 10 nmol) into the lateral ventricle did not disrupt&hellip;<span class="activity-read-more" id="activity-read-more-142671"><a href="https://recash.wpsoul.net/activity/p/142671/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">95164e33c7860c9ca5a734d86984794d</guid>
				<title>Kragelund Blum posted an update: A novel noninterpenetrated tetranuclear cobalt(II)-based [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/136633/</link>
				<pubDate>Thu, 02 Jan 2025 09:45:48 +0000</pubDate>

									<content:encoded><![CDATA[<p>A novel noninterpenetrated tetranuclear cobalt(II)-based metal-organic framework, (NH4)2·[Co4(μ3-OH)2(ina)2(pip)3]·4EtOH·H2O (simplified as NbU-10·S), constructed by mix linkers was synthesized by a hydrothermal method. Interestingly, the presence of a hydrophobic benzene ring in the organic linker makes NbU-10·S exhibit high stability in high&hellip;<span class="activity-read-more" id="activity-read-more-136633"><a href="https://recash.wpsoul.net/activity/p/136633/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2d65fce7a42da6949023178427b81f4f</guid>
				<title>Kragelund Blum posted an update: The conventional &quot;top-down&quot;, &quot;bottom-up&quot; and [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/128105/</link>
				<pubDate>Mon, 30 Dec 2024 10:29:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>The conventional &#8220;top-down&#8221;, &#8220;bottom-up&#8221; and &#8220;combination&#8221; approaches of generating drug nanocrystals produce a &#8220;nanosuspension&#8221; (NS). It requires significant downstream processing for drying the liquid by suitable means followed by its granulation to develop an oral solid dosage form (OSD). In this paper, we used a novel, spray drying-based&hellip;<span class="activity-read-more" id="activity-read-more-128105"><a href="https://recash.wpsoul.net/activity/p/128105/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b34d5d22fe786754169ce2d4d8a0ed05</guid>
				<title>Kragelund Blum became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/90914/</link>
				<pubDate>Fri, 20 Dec 2024 09:04:06 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>